Drug intelligence / Profile preview

rNRG4

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
Administration
Central (intracerebroventricular, Preclinical), Intravenous (preclinical), Systemic
01

Overview

Recombinant neuregulin 4 (rNRG4) is a laboratory-synthesized protein form of neuregulin 4 (Nrg4), an adipokine secreted primarily by adipose tissue. Nrg4 acts as a ligand for the ErbB4 tyrosine kinase receptor, modulating metabolic homeostasis by stimulating ErbB4 signaling in target tissues, including the hypothalamus and endothelial cells. rNRG4 has shown potential in reducing obesity and related metabolic disorders by acting centrally to influence energy expenditure, suppressing appetite through ErbB4-oxytocin neuron signaling in the hypothalamus, and regulating inflammation in vascular endothelium via inhibition of the NF-κB pathway. It is being investigated primarily for metabolic disease (obesity, metabolic syndrome), and preclinical studies indicate additional benefit in vascular inflammation and atherosclerosis.

Other names
recombinant neuregulin 4recombinant NRG4rNrg4rNrg-4rNrg 4
02

Targets

ERBB4 (Erb-b2 receptor tyrosine kinase 4)

Beyond the preview

Go deeper on rNRG4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rNRG4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call